Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.43 |
| ▸ | ADH1C | P00326 | 3/20 | 0.43 |
| ▸ | ADH1A | P07327 | 3/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10282957 | 0.82 | ADH1B (0.37) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL15471615 | 0.79 | ADH1B (0.35) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL271892 | 0.77 | — | — | |
| SCHEMBL10433346 | 0.75 | — | — | |
| SCHEMBL6826702 | 0.75 | — | — | |
| SCHEMBL277866 | 0.74 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL271373 | 0.74 | — | — | |
| SCHEMBL14473845 | 0.73 | ADH1B (0.42) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL24138428 | 0.73 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL22546104 | 0.72 | ADH1B (0.41) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11576928-B2 | Substituted phenyl boronic acid containing polymers and methods of use | GLYSCEND, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| US-11246963-B2 | Compositions and methods for delivery of hydrophobic active agents | SURMODICS, INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20210403625-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | GLYSCEND, INC. | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11576928-B2 | Substituted phenyl boronic acid containing polymers and methods of use | SLC10A2, PYGL, SLC10A1 | ADH1B 1152/4885ADH1C 1886/4885ADH1A 1570/4885 |
| US-20210403625-A1 | BORONIC ACID POLYMERS AND METHODS OF USE | SLC10A2, SI, PYGL | ADH1B 781/4885ADH1C 1242/4885ADH1A 1171/4885 |
| US-11246963-B2 | Compositions and methods for delivery of hydrophobic active agents | PAICS, HNRNPA1, INCENP | ADH1B 3600/4885ADH1C 2054/4885ADH1A 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.